
Lii Inc.
Japan · HealthTech · Undetermined
BILIX
South Korea · Biotech & life sciences · Series A
Compatibility /100
59/100
High potentialWhy talk
- Lii Inc. has the customers BILIX is still looking for — a channel Lii Inc. can open.
- Lii Inc. likely needs funding — BILIX (South Korea, Series A, $13.3M raised) can offer investor introductions (inferred from public profile).
- Complementary sectors: HealthTech × Biotech & life sciences — room for a joint offer or co-selling.
Score anatomy
Each segment is what one dimension adds, out of 100.
Score by goal
Dimension by dimension
Needs ↔ offers
16.3 / 25 pts
Value flows both ways.
- Lii Inc. likely needs funding — BILIX (South Korea, Series A, $13.3M raised) can offer investor introductions (inferred from public profile).
- BILIX likely needs first paying customers — Lii Inc. can offer access to its customer base (inferred from public profile).
Market bridge
7.5 / 15 pts
Regional bridge.
- BILIX (South Korea) is a regional neighbour in Asia — a natural first step for cross-border expansion.
Customer potential
20.0 / 40 pts
Some customer potential.
- Lii Inc. has the customers BILIX is still looking for — a channel Lii Inc. can open.
Sector synergy
12.8 / 15 pts
Complementary sectors.
- Complementary sectors: HealthTech × Biotech & life sciences — room for a joint offer or co-selling.
Stage complementarity
2.3 / 5 pts
Weak stage signal.
- BILIX has raised about $13.3M — investor introductions are realistic.
- Stage not comparable (Undetermined / Series A).
How the score works
Each dimension gives a value between 0 and 1, multiplied by its weight; the compatibility is the sum (0–100). Weights for “Customers”: Needs ↔ offers 25, Market bridge 15, Customer potential 40, Sector synergy 15, Stage complementarity 5. Declared needs and offers count fully; when a startup has declared nothing, a few needs/offers are inferred from its public profile (for example, no known traction ⇒ needs customers) and count at half value.
Potential blends compatibility (65%) with the mean global score of both startups (35%): 56/100 — high from 50, medium from 36.